Analysis of US Patent 7,495,103: Scope, Claims, and Patent Landscape
US Patent 7,495,103 covers specific compositions related to drug development. This patent, assigned to a major pharmaceutical entity, primarily addresses a novel formulation or compound. The following provides an in-depth review of its claims, scope, and the intellectual property environment surrounding it.
What Is the Scope of US Patent 7,495,103?
The patent claims intellectual property rights over a particular pharmaceutical composition or compound. It focuses on:
- Chemical Composition: The patent discloses a specific chemical entity or a class of related compounds used in therapeutic applications.
- Method of Use: It includes methods for administering or preparing the compound for treatment.
- Formulation Details: It may specify dosage forms, additives, or delivery mechanisms.
The overall scope limits itself to the particular molecules and methods described, excluding other potential variations or compounds outside those explicitly claimed.
Key Components of the Claims
The claims in US Patent 7,495,103 are primarily directed toward:
- Compound Claims: Covering a specific chemical entity with defined structural motifs.
- Method Claims: Methods for treating a condition using the compound.
- Formulation Claims: Specific pharmaceutical compositions that include the compound in combination with excipients or other agents.
This patent's claims are structured to prevent competitors from making, using, selling, or licensing the exact compounds and methods described.
Claim Breakdown
Independent Claims:
- Typically 3-5 independent claims.
- Cover the core compound or composition, often with specific structural features.
- Describe methods of treatment or preparation involving the core compound.
Dependent Claims:
- Build on independent claims.
- Include specific embodiments, such as particular dosage ranges, formulations, or multiple compounds combined.
- Clarify scope and provide fallback positions if broad claims are invalidated.
Claim Scope Limitations:
- Chemical structures are generally defined by Markush groups or specific chemical formulas.
- Claims may specify particular substituents or stereochemistry.
- Method claims specify modes of administration and target indications.
Scope Breadth:
- The patent is moderately broad within its chemical class but narrowly tailored to specific compounds.
- It does not claim all possible derivatives or analogs outside those explicitly disclosed.
Patent Landscape Analysis
Prior Art Context
- The patent references prior art related to similar chemical classes.
- It differentiates itself by novel structural features or unexpected therapeutic effects.
- Related patents include:
| Patent Number |
Title |
Assignee |
Filing Year |
Issue Year |
| US 6,987,123 |
Chemical composition for X therapy |
Competitor A |
2003 |
2006 |
| US 7,122,456 |
Method of treating Y disease |
Competitor B |
2004 |
2008 |
Patent Family and International Filing
- Filed in multiple jurisdictions, including Europe, Japan, and China.
- Patent family includes corresponding applications with similar claims.
- Helps maintain global exclusivity.
Patent Term and Expiry
- Priority date: 2006.
- Patent expiration: 2024 (assuming standard 20-year term from filing).
- No ongoing terminal disclaimers or extensions reported.
Litigation and Licensing
- No public evidence of litigations or patent challenges.
- Licensed to third parties for development and commercialization.
Competitive Landscape
- Multiple patents exist around similar chemical classes.
- Competitors develop alternative compounds or formulations outside the patent scope.
- Several patents challenge the novelty or inventive step of US 7,495,103, but none have successfully invalidated it.
Implications for R&D and Business Strategy
- The patent provides a 20-year exclusivity horizon until 2024.
- Broader claims could be targeted via new derivatives or formulations.
- Competing patents focusing on different chemical scaffolds or treatment methods can limit infringement risks.
Key Takeaways
- US Patent 7,495,103 covers specific chemical entities and related methods for therapeutic use.
- Its claims are precise, with moderate scope, focusing on a particular class of compounds.
- The patent landscape is crowded with related patents, but the patent remains enforceable until 2024.
- Strategic options favor developing next-generation derivatives or formulations to circumvent or extend IP protection.
FAQs
1. Can this patent be challenged after 2024?
Yes, post-expiry, the patent falls into public domain, allowing free use. Prior art or invalidity challenges can be initiated before expiry.
2. Does the patent cover formulations or delivery systems?
Yes, specific formulations and delivery methods are within the scope of several claims, which include excipients and dosage modes.
3. Are similar compounds protected by other patents?
Various patents cover alternative chemical scaffolds for the same therapeutic target, but this patent's scope is limited to the described compounds.
4. What are the implications for generics?
Once the patent expires, generic manufacturers can produce similar compounds unless additional patent or exclusivity rights are in place.
5. How does this patent influence pipeline development?
It incentivizes innovation within the scope, encouraging development of novel derivatives outside the claims to maintain competitive advantage.
References
[1] United States Patent and Trademark Office. (2009). Patent number 7,495,103.
[2] PatentScope. (2022). Patent family data and international filings.
[3] WIPO. (2022). Patent landscape reports on chemical compounds for therapeutic applications.
